Swiss SME applying AI, remote sensing, and biomarker analysis to medical diagnostics and sustainable agriculture across international MSCA consortia.
TOELT GmbH is a Swiss technology SME based near Zurich that applies AI, sensor data analysis, and computational modelling to complex diagnostic and measurement challenges. In medical research, they contribute to early detection of neurodevelopmental conditions in premature newborns using neuroimaging, eye tracking, and biomarker analysis. In agricultural research, they bring remote sensing and spectrophotometry skills to sustainable farming and techno-economic modelling. Their consistent thread is translating multi-modal data into decision-support systems, applied across domains where early, accurate interpretation of sensor data matters.
PARENT project (2020-2025) applies neuroimaging, eye tracking, and AI-driven mechanistic modelling to early diagnosis of motor and cognitive impairments in premature newborns and infants with congenital heart disease.
PARENT project explicitly lists artificial intelligence and support decision systems among its keywords, suggesting TOELT contributes software or modelling tools that translate clinical data into actionable clinical guidance.
SUSTAINABLE project (2021-2025) lists remote sensing and spectrophotometry as core keywords, indicating TOELT applies optical and spectral measurement techniques to agricultural monitoring or crop analysis.
SUSTAINABLE project includes techno-economic models as a keyword, suggesting TOELT contributes cost-benefit or feasibility analysis alongside the technical sensing components.
TOELT's first H2020 engagement (PARENT, 2020) was squarely in neonatal medicine — neuroimaging, cerebral palsy biomarkers, and AI-assisted clinical decision tools for premature newborns. Their second project (SUSTAINABLE, 2021) shifted entirely to sustainable agriculture: remote sensing, spectrophotometry, and techno-economic modelling. With only two projects starting just one year apart, it is more accurate to describe these as two parallel specialisations rather than a true evolution — the domain pivot is sharp and the timeline is too compressed to call it a directional trend.
TOELT appears to be positioning itself as a cross-domain applied measurement and modelling company, capable of moving its core sensor-data and AI capabilities into whatever field its MSCA research partners operate in — but with only two projects, future direction remains genuinely open.
TOELT has never led an H2020 project, participating exclusively as a consortium partner in both engagements. Both projects used MSCA schemes — one a training network (ITN), one a staff exchange (RISE) — which means TOELT's role likely involves hosting or sending researchers rather than driving project strategy. Their 26 partners across 10 countries suggest they operate in reasonably large, internationally diverse consortia rather than small bilateral arrangements.
TOELT has built connections with 26 unique consortium partners spanning 10 countries through just two projects, reflecting the naturally broad network that MSCA training and exchange schemes generate. No geographic concentration is apparent from the available data.
TOELT is an unusual SME: a small Swiss company that has operated in two entirely different research domains — neonatal neurology and precision agriculture — both times by offering data analysis, AI, and sensing expertise rather than domain-specific infrastructure. Their Swiss base and MSCA track record make them an attractive host organisation for Marie Curie fellows seeking industry secondments. For consortium builders, they offer a private-sector stamp and technical AI/sensing competence without requiring deep sector commitment from their partners.
